Top tips for reducing pharmaceutical bioburden and maximizing microbial limits testing

As regulations become more stringent, microbiological testing is becoming more critical than ever in ensuring the quality of pharmaceutical products. In this application note from Cytiva, explore how to control costs by reducing retest delays and investigations caused by cross-contamination, such as through fast, flexible testing with the Membrane Filtration (MF) technique, and implementing hardware and workflow approaches.